PHM7 Stock Chart & Stats
€58.78
€0.36(0.56%)
At close: 4:00 PM EDT
€58.78
€0.36(0.56%)
Day’s Range― - ―
52-Week Range€46.62 - €67.60
Previous CloseN/A
Volume39.00
Average Volume (3M)2.06K
Market Cap
€111.68B
Enterprise Value€142.42B
Total Cash (Recent Filing)€2.37B
Total Debt (Recent Filing)€24.58B
Price to Earnings (P/E)15.8
Beta-0.03
Next Earnings
Oct 29, 2026EPS Estimate
1.34Next Dividend Ex-DateN/A
Dividend Yield5.57%
Share Statistics
EPS (TTM)4.74
Shares Outstanding1,669,743,900
10 Day Avg. Volume2,469
30 Day Avg. Volume2,058
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)-27.61
Price to Sales (P/S)4.80
P/FCF Ratio10.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€60.91Price Target Upside3.62% Upside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)5.07
Revenue Forecast (FY)€18.33B
Bulls Say, Bears Say
Bulls Say
High Profitability And Cash GenerationExceptional profitability and cash conversion provide a durable foundation for Altria’s business. Strong margins reflect brand strength, pricing power and scale, while substantial free cash flow supports dividends, investment in growth platforms and the ability to manage obligations over the next several quarters.
On! PLUS Distribution And Share GainsThe expansion of on! PLUS into approximately 90% of nicotine product volume gives Altria broader distribution for a smoke-free product. Rising retail share and repeat purchases indicate improving consumer traction, supporting a potentially durable growth avenue as nicotine users shift away from cigarettes.
Regulatory Authorization Supports Smoke-free PortfolioFDA authorization for three JUUL2 products provides a clearer legal pathway for a key Altria investment and supports the company’s smoke-free strategy. The finding that some adult smokers completely switched to authorized products may strengthen the long-term relevance of regulated alternatives.
Bears Say
High Leverage And Negative EquityAltria’s large debt burden and negative accounting equity reduce financial flexibility and leave a thin capital cushion. Although current cash generation is strong, elevated leverage increases sensitivity to operating weakness, limits room for investment and can constrain future capital allocation.
Secular Cigarette Volume DeclinesPersistent cigarette volume contraction remains a structural challenge because smokeable products are historically Altria’s largest profit driver. Pricing can offset some volume loss, but continued declines gradually narrow the consumable base and increase dependence on price, mix and smoke-free product development.
Oral Tobacco Weakness And Trade-downWeak oral tobacco profitability and shipment declines indicate that growth in smoke-free products is not yet uniformly established. Rising discount share and consumer trade-down also pressure product mix, potentially reducing margins and requiring promotional investment to defend volume and build newer offerings.
Altria Group News
PHM7 FAQ
What was Altria Group Inc’s price range in the past 12 months?
Altria Group Inc lowest stock price was €46.62 and its highest was €67.60 in the past 12 months.
What is Altria Group Inc’s market cap?
Altria Group Inc’s market cap is €111.68B.
When is Altria Group Inc’s upcoming earnings report date?
Altria Group Inc’s upcoming earnings report date is Oct 29, 2026 which is in 10 days.
How were Altria Group Inc’s earnings last quarter?
Altria Group Inc released its earnings results on Jul 30, 2026. The company reported €1.318 earnings per share for the quarter, missing the consensus estimate of €1.332 by -€0.014.
Is Altria Group Inc overvalued?
According to Wall Street analysts Altria Group Inc’s price is currently Undervalued.
Does Altria Group Inc pay dividends?
Altria Group Inc pays a Quarterly dividend of €0.962 which represents an annual dividend yield of 5.57%. See more information on Altria Group Inc dividends here
What is Altria Group Inc’s EPS estimate?
Altria Group Inc’s EPS estimate is 1.34.
How many shares outstanding does Altria Group Inc have?
Altria Group Inc has 1,669,743,900 shares outstanding.
What happened to Altria Group Inc’s price movement after its last earnings report?
Altria Group Inc reported an EPS of €1.318 in its last earnings report, missing expectations of €1.332. Following the earnings report the stock price went down -10.202%.
Which hedge fund is a major shareholder of Altria Group Inc?
Currently, no hedge funds are holding shares in DE:PHM7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Altria Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€60.91 (3.62% Upside)
€60.91 (3.62% Upside)
Blogger Sentiment
Bullish
DE:PHM7 Sentiment 60%
Sector Average 63%
Sector Average 63%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.79%
12-Months-Change
Fundamentals
Return on Equity
-265.17%
Trailing 12-Months
Asset Growth
3.22%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Altria Group Inc
Operating across the United States through its subsidiaries, Altria Group, Inc. is a prominent manufacturer and marketer of both combustible and oral tobacco items. Its portfolio features cigarettes, primarily under the iconic Marlboro brand, alongside cigars and pipe tobacco mainly offered as Black & Mild. The enterprise further provides an assortment of moist smokeless tobacco products, including Copenhagen, Skoal, Red Seal, and Husky, in addition to its on! brand of oral nicotine pouches. Altria distributes its merchandise chiefly to wholesale partners, such as independent distributors, and directly to substantial retail organizations, including major chain stores. The corporation, founded in 1822, maintains its principal offices in Richmond, Virginia.
PHM7 Company Deck
PHM7 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized solid financial performance and disciplined execution: EPS growth (Q2 +2.8%, H1 +4.9%), expanded smokeable margins, a narrowed full-year EPS range, substantial shareholder returns (~$3.9 billion YTD), ABI earnings growth (+21.5%), and strategic expansion of the smoke-free on! PLUS offering to ~120,000 stores. Offsetting items included a weaker Oral Tobacco quarter (adjusted OCI down 8% Q2), reported shipment declines affected by trade inventory timing, ongoing cigarette volume declines (adjusted ~-4.5% Q2) and continued consumer trade-down toward discount brands. Management highlighted favorable regulatory and enforcement developments that could benefit regulated smoke-free products over time. On balance, the positives around profitability, cash returns, regulatory tailwinds and product expansion were presented as outweighing near-term volume and segment-specific headwinds.View all DE:PHM7 earnings summariesPHM7 Revenue Breakdown
88.00% Smokeable products
12.04% Oral tobacco products
-0.06% E-vapor products
0.02% All other
PHM7 Stock 12 Month Forecast
Average Price Target
€60.91
▲(3.62% Upside)
Technical Analysis
British American Tobacco
―
Philip Morris
―
22nd Century
―
Turning Point Brands
―
RLX Technology
―